| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |